Inventor
AGGEN JAMES BRADLEY
US27 patents
⚠️ This page may combine multiple inventors who share the name “AGGEN JAMES BRADLEY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ACHAOGEN INC
10 patentsUS8383596B2Feb 26, 2013
Antibacterial aminoglycoside analogs
ACHAOGEN INC17 citations91
US9688711B2Jun 27, 2017
Antibacterial aminoglycoside analogs
ACHAOGEN INC7 citations83
US9266919B2Feb 23, 2016
Antibacterial aminoglycoside analogs
ACHAOGEN INC4 citations83
US8822424B2Sep 2, 2014
Antibacterial aminoglycoside analogs
ACHAOGEN INC7 citations83
US8372813B2Feb 12, 2013
Antibacterial aminoglycoside analogs
ACHAOGEN INC9 citations83
US8367625B2Feb 5, 2013
Antibacterial aminoglycoside analogs
ACHAOGEN INC10 citations83
US9403758B2Aug 2, 2016
Antibacterial agents
ACHAOGEN INC8 citations80
USRE47741ENov 26, 2019
Antibacterial aminoglycoside analogs
ACHAOGEN INC1 citations62
US8653041B2Feb 18, 2014
Antibacterial aminoglycoside analogs
ACHAOGEN INC3 citations61
US9701622B2Jul 11, 2017
Antibacterial agents
ACHAOGEN INC0 citations48
REVOLUTION MEDICINES INC
6 patentsUS11364300B2Jun 21, 2022
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC6 citations84
US10980889B1Apr 20, 2021
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC8 citations81
US12048749B2Jul 30, 2024
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC3 citations73
US12187746B2Jan 7, 2025
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US11685749B2Jun 27, 2023
C26-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC5 citations72
US12544448B2Feb 10, 2026
C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors
REVOLUTION MEDICINES INC0 citations61